-
1
المؤلفون: Pentheroudakis, George, Pavlidis, Nicholas
المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Pentheroudakis, George [0000-0002-6632-2462]
المصدر: Expert opinion on pharmacotherapy
مصطلحات موضوعية: Drug dose regimen, Oncology, Hydrocortisone, Carcinogenesis, Life expectancy, medicine.medical_treatment, Dermatitis, Review, Antipyretic agent, Diagnostic accuracy, Dna topoisomerases, Breast cancer, Leukoencephalopathy, Antineoplastic agents, Meningeal Neoplasms, Pharmacology (medical), Enzyme Inhibitors, Cerebrospinal fluid analysis, Injections, Spinal, Adenocarcinoma/pathology, Enzyme Inhibitors/therapeutic use, Palliative Care, Headache, General Medicine, Prognosis, Antineoplastic, Alkylating, Management, Arachnoid Cysts, Clinical trial, Nuclear magnetic resonance imaging, Spinal cord disease, Randomized controlled trials, Reverse transcription polymerase chain reaction, fluid/therapeutic use, Topotecan/therapeutic use, Rituximab, Lymphoma/pathology, Human, Antimetabolites, Antineoplastic, medicine.medical_specialty, Leptomeninx, Bone marrow suppression, Vomiting, Leptomeningeal, Adenocarcinoma, Irinotecan, Beta 2 microglobulin, Disease association, Drug formulation, Meningism, Humans, Combined Modality Therapy, Molecular mechanics, Antineoplastic Agents, Alkylating, High risk population, Steroid, Pharmacology, Carcinoma/*drug therapy/radiotherapy/secondary, Type i, medicine.disease, Lymphoma, Radiation therapy, Myelin basic protein, Methotrexate, Arachnoiditis, Delayed-Action Preparations, Laboratory diagnosis, Risk factor, Topoisomerase I Inhibitors, Palliative care, Antimetabolites, Meningeal Neoplasms/*drug therapy/radiotherapy/secondary, Dexamethasone, Cancer risk, Arachnoid cysts, Photophobia, Thiotepa/administration & dosage/cerebrospinal fluid/therapeutic use, Nephrotoxicity, Randomized Controlled Trials as Topic, Meningeal metastasis, Leukemia, Cytarabine, Folinic acid, Lactate dehydrogenase, Nausea, Combined modality therapy, Enzyme inhibitors, Antineoplastic Agents, Alkylating/administration & dosage/cerebrospinal, Sensitivity and specificity, Cranial irradiation, Injections, Intravenous, Cytarabine/administration & dosage/cerebrospinal fluid/therapeutic use, Meningeal neoplasms, Mafosfamide, Intravenous, Carcinomatous meningitis, Algorithms, Drug elimination, Fever, Spinal, Liver toxicity, Drug response, Cerebellum disease, Arachnoid Cysts/*drug therapy/etiology/radiotherapy, Drug half life, Neuroimaging, Malignancy, Injections, Methotrexate/administration & dosage/cerebrospinal fluid/therapeutic use, Aseptic meningitis, Mucosa inflammation, Internal medicine, Computer assisted tomography, Temozolomide, medicine, Leukemia/pathology, Antimetabolites, Antineoplastic/administration & dosage/cerebrospinal, Vasculotropin, Performance status, business.industry, Carcinoma, Trastuzumab, Cancer survival, Surgery, Drug efficacy, Carcinoembryonic antigen, Delayed-action preparations, Cranial Irradiation, Antiemetic agent, Topotecan, Cytology, business, Thiotepa
-
2
المؤلفون: Markus Borner, Damien Dietrich, Richard Herrmann, Daniel Rauch, Marie Wernli, Jacqueline Simone Bernhard, Arnaud Roth, Piercarlo Saletti, Doris Lanz, Patrik Olivier Brauchli, Dieter Koeberle, Hanspeter Honegger, R. A. Popescu
المصدر: Annals of Oncology, Vol. 16, No 2 (2005) pp. 282-8
مصطلحات موضوعية: Adult, Male, Antimetabolites, Antineoplastic, medicine.medical_specialty, Phases of clinical research, Antimetabolites, Antineoplastic/administration & dosage/adverse effects/therapeutic use, Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives/therapeutic use, ddc:616.07, Neutropenia, Irinotecan, Deoxycytidine, Gastroenterology, Drug Administration Schedule, Capecitabine, Internal medicine, medicine, Clinical endpoint, Humans, Infusions, Intravenous, Fluorouracil/analogs & derivatives, Aged, ddc:616, XELIRI, ddc:617, Performance status, business.industry, Camptothecin/administration & dosage/adverse effects/analogs & derivatives/therapeutic use, Hematology, Middle Aged, medicine.disease, Antineoplastic Agents, Phytogenic, Confidence interval, Surgery, Treatment Outcome, Oncology, Antineoplastic Agents, Phytogenic/administration & dosage/adverse effects/therapeutic use, Colorectal Neoplasms/drug therapy/pathology, Quality of Life, Camptothecin, Female, Fluorouracil, Colorectal Neoplasms, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::098f35887ea4bb064f93c952124d315d
https://doi.org/10.1093/annonc/mdi047 -
3
المؤلفون: Piercarlo Saletti, M. Wernli, Hanspeter Honegger, Monica Castiglione-Gertsch, Richard Herrmann, Silvia Hanselmann, Peter Brauchli, Roger Stupp, Markus Borner, B. Pestalozzi, A. Roth, Rudolf Morant, Aron Goldhirsch, Samuel Müller, Daniel Dietrich
المصدر: Journal of Clinical Oncology, Vol. 20, No 7 (2002) pp. 1759-66
مصطلحات موضوعية: Male, Cancer Research, Organoplatinum Compounds, Colorectal cancer, Antimetabolites, Antineoplastic/administration & dosage, medicine.medical_treatment, Phases of clinical research, Gastroenterology, Deoxycytidine, Antineoplastic Combined Chemotherapy Protocols, Fluorouracil/analogs & derivatives, ddc:616, ddc:617, Colorectal Neoplasms/drug therapy, Middle Aged, Oxaliplatin, Treatment Outcome, Oncology, Tolerability, Diarrhea/chemically induced, Female, Fluorouracil, Colorectal Neoplasms, medicine.drug, Adult, Diarrhea, medicine.medical_specialty, Antimetabolites, Antineoplastic, Antineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic use, Adenocarcinoma, Drug Administration Schedule, Capecitabine, Adenocarcinoma/drug therapy, Internal medicine, medicine, Deoxycytidine/administration & dosage/analogs & derivatives, Humans, Organoplatinum Compounds/administration & dosage, Aged, Neoplasm Staging, Chemotherapy, Performance status, business.industry, medicine.disease, digestive system diseases, Surgery, Regimen, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e51a7d0fa4e25d9b80773267cff71a9
https://pubmed.ncbi.nlm.nih.gov/11919232
PDF full text from Publisher